Hudson Clean Energy Partners Raises Debut Fund Successfully

Hudson Clean Energy Partners, L.P., a debut fund from Hudson Clean Energy Partners, has achieved its $1 billion target successfully. Hudson Clean Energy Partners has announced the closure of the fund after reaching the target. The capital will be deployed by the company to expand its current clean energy investment portfolio.

Hudson Clean Energy Partners was found in the year 2007 and is led by renewable energy experts, Neil Auerbach and John Cavalier.  Neil Auerbach had found the U.S Alternative Energy investing business for Goldman Sachs Group. He had led many successful renewable energy investments for Goldman Sachs. John Cavalier had served as Chairman of the Energy Group and Head of Credit Suisse's Global Renewable Energy efforts and he was formerly Vice Chairman of Credit Suisse's Investment Banking Department.

John Cavalier, Hudson Co-Managing Partner, remarked that they are delighted to exceed the $1 billion fund target even during recession and global economic downtrend. He added that this achievement is a proof for their outstanding success in their renewable energy investments and excellence of the Hudson team.

Neil Auerbach, Hudson Founder and Co-Managing Partner, said that they are extremely pleased to raise the capital from a diverse group of global investors during these challenging economic environments. This shows the commitment on the part of investors to invest in renewable energy, and Hudson will be deploying this capital selectively in successful clean energy companies.

Some of the renewable energy companies in Hudson’s portfolio include Recurrent Energy, Element Power, CaliSolar, SoloPower, and Wind to Power Systems. Lead placement agent for the fund was C.P. Eaton Partners LLC and it is assisted by Poalim Ventures Ltd. and Credit Suisse Securities (USA) LLC (Alternative Investments).

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.